United Kingdom (UK) Neurological Disorder Drugs Market (2025-2031) | Competitive Landscape, Companies, Industry, Outlook, Segmentation, Growth, Size & Revenue, Share, Value, Trends, Analysis, Forecast

Market Forecast By Indication (Epilepsy, Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) And Competitive Landscape
Product Code: ETC9949744 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Neurological Disorder Drugs Market Outlook
  • Market Size of United Kingdom (UK) Neurological Disorder Drugs Market, 2024
  • Forecast of United Kingdom (UK) Neurological Disorder Drugs Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Neurological Disorder Drugs Market Trend Evolution
  • United Kingdom (UK) Neurological Disorder Drugs Market Drivers and Challenges
  • United Kingdom (UK) Neurological Disorder Drugs Price Trends
  • United Kingdom (UK) Neurological Disorder Drugs Porter's Five Forces
  • United Kingdom (UK) Neurological Disorder Drugs Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Epilepsy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Alzheimers Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Parkinsons Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Multiple Sclerosis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Cerebrovascular Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Cholinesterase Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By NMDA Receptor Antagonists for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Antiepileptic for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Antipsychotic and Antidepressant for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) Neurological Disorder Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • United Kingdom (UK) Neurological Disorder Drugs Top Companies Market Share
  • United Kingdom (UK) Neurological Disorder Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Neurological Disorder Drugs Company Profiles
  • United Kingdom (UK) Neurological Disorder Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?
6Wresearch actively monitors the United Kingdom (UK) Neurological Disorder Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Neurological Disorder Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Neurological Disorder Drugs Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Neurological Disorder Drugs Market - Industry Life Cycle

3.4 United Kingdom (UK) Neurological Disorder Drugs Market - Porter's Five Forces

3.5 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United Kingdom (UK) Neurological Disorder Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in the United Kingdom

4.2.2 Rising awareness and diagnosis rates of neurological disorders

4.2.3 Technological advancements in drug development for neurological disorders

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for neurological disorder drugs

4.3.2 High cost associated with research and development of new drugs

4.3.3 Potential side effects and safety concerns associated with neurological disorder drugs

5 United Kingdom (UK) Neurological Disorder Drugs Market Trends

6 United Kingdom (UK) Neurological Disorder Drugs Market, By Types

6.1 United Kingdom (UK) Neurological Disorder Drugs Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.1.4 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F

6.1.5 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F

6.1.6 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.7 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Cerebrovascular Disease, 2021- 2031F

6.1.8 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Neurological Disorder Drugs Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.3 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F

6.2.4 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Antiepileptic, 2021- 2031F

6.2.5 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Antipsychotic and Antidepressant, 2021- 2031F

6.2.6 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Neurological Disorder Drugs Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.4 United Kingdom (UK) Neurological Disorder Drugs Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.5 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.5 United Kingdom (UK) Neurological Disorder Drugs Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.5.4 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.5 United Kingdom (UK) Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) Neurological Disorder Drugs Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Neurological Disorder Drugs Market Export to Major Countries

7.2 United Kingdom (UK) Neurological Disorder Drugs Market Imports from Major Countries

8 United Kingdom (UK) Neurological Disorder Drugs Market Key Performance Indicators

8.1 Patient enrollment in clinical trials for neurological disorder drugs

8.2 Adoption rate of new treatment options for neurological disorders

8.3 Number of research partnerships and collaborations in the neurological disorder drugs market

9 United Kingdom (UK) Neurological Disorder Drugs Market - Opportunity Assessment

9.1 United Kingdom (UK) Neurological Disorder Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United Kingdom (UK) Neurological Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 United Kingdom (UK) Neurological Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United Kingdom (UK) Neurological Disorder Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 United Kingdom (UK) Neurological Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United Kingdom (UK) Neurological Disorder Drugs Market - Competitive Landscape

10.1 United Kingdom (UK) Neurological Disorder Drugs Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Neurological Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Thought Leadership and Analyst Meet

Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Thought Leadership and Analyst Meet
Visitors exploring electric vehicle technologies and innovations at EV India Expo 2021
Thought Leadership and Analyst Meet
View All

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Stationery & Paper Expo Saudi Arabia 2026

Stationery & Paper Expo Saudi Arabia 2026

Kids & Toys Expo Saudi Arabia 2026

Kids & Toys Expo Saudi Arabia 2026

Gifts & Homeware Expo Saudi Arabia 2026

Gifts & Homeware Expo Saudi Arabia 2026

Smart Home Expo 2026

Smart Home Expo 2026

Industrial Facilities Management Expo 2025

Industrial Facilities Management Expo 2025

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Thought Leadership and Analyst Meet
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
Agriculture
©2025 6Wresearch, All Right Reserved